Traders should view the reduced net loss as misleading — it is driven entirely by non-recurring gains. The company has no revenue, is burning cash rapidly, and faces a near-term existential liquidity crisis. Any equity offering would likely be dilutive given the low cash balance and urgent need for capital.
Price Chart
Executive Summary
Exicure reported its 2025 financial results, showing a reduced net loss of $4.9 million compared to $9.7 million in 2024, driven primarily by a $6.0 million gain from early lease termination. However, revenue dropped to zero from $500,000, and cash reserves fell sharply to $3.7 million from $12.5 million, with management explicitly warning of insufficient liquidity to fund operations for the next 12 months without substantial new financing.
Key Financial Metrics
Key Facts
- Net loss decreased to $4.9 million in 2025 from $9.7 million in 2024, but only due to a one-time $6.0 million gain from lease liability reversal.
- Revenue declined to $0 in 2025 from $500,000 in 2024.
- Cash and cash equivalents dropped 70% year-over-year to $3.7 million, down from $12.5 million.
- Management states current liquidity is insufficient to fund operations for the next 12 months.
- R&D expenses increased to $3.3 million in 2025 from $0 in 2024 due to acquisition of GPCR Therapeutics.
- Company is actively exploring strategic alternatives and requires immediate financing to survive.
Financial Impact
Cash burn of $8.8 million in 2025 (from $12.5M to $3.7M), with no revenue and a structural operating deficit masked by non-recurring gains.
Risk Factors
- Imminent risk of delisting or bankruptcy if financing is not secured.
- Dilution risk from potential emergency capital raise at unfavorable terms.
- No commercial revenue and minimal operating activity to support valuation.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 2 press releases from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3262597 |
| PRESS-RELEASE Data (Synthetic) | press-3262598 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 16, 2026 5w ago | 8-K | $1.33 $1.15 | ▲ +13.53% | ▲ +16.71% | $1.09 (+18.05%) |
Jun 30, 2026 16w ago | 8-K | $2.08 $1.75 | ▼ −15.87% | ▼ −14.84% | $1.09 (−47.60%) |
Jun 1, 2026 21w ago | Press Release | $3.11 $1.98 | ▼ −36.33% | ▼ −34.77% | $1.09 (−64.95%) |
Jun 1, 2026 21w ago | 8-K | $3.33 $2.08 | ▼ −37.54% | ▼ −36.24% | $1.09 (−67.27%) |
Apr 10, 2026 28w ago | 8-K | $3.85 $3.38 | ▼ −12.16% | ▼ −19.89% | $1.09 (−71.67%) |
Mar 25, 2026 30w ago | Press Release | $4.61 $3.47 | ▲ +24.73% | ▲ +35.39% | $1.09 (+76.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers